Screener
Olema Pharmaceuticals, Inc. OLMA Proceeds From Issuance Of Shares Under At The Market Offering
Proceeds From Issuance Of Shares Under At The Market Offering at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept olma:ProceedsFromIssuanceOfSharesUnderAtTheMarketOffering.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
FAQ
- What is Olema Pharmaceuticals, Inc.'s proceeds from issuance of shares under at the market offering?
- Olema Pharmaceuticals, Inc. (OLMA) reported proceeds from issuance of shares under at the market offering of $41.92M in Q1 2026.
- What does proceeds from issuance of shares under at the market offering mean?
- This captures cash proceeds from selling shares directly into the open market at prevailing market prices, often through an 'at-the-market' (ATM) facility. This provides the company with flexible, incremental access to capital without the need for a formal underwritten offering. It is a key indicator of the company's ability to manage its cash runway efficiently.
Ask your AI about Olema Pharmaceuticals, Inc.'s proceeds from issuance of shares under at the market offering.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude